리가켐바이오(141080) 주가전망 및 투자전략 – 2026-03-14
K-바이오의 자존심이자 글로벌 ADC(항체약물접합체) 시장의 대장주로 우뚝 선 리가켐바이오(141080)에 대해 정리해 보았습니다.
K-바이오의 자존심이자 글로벌 ADC(항체약물접합체) 시장의 대장주로 우뚝 선 리가켐바이오(141080)에 대해 정리해 보았습니다.
One cannot help but observe the 2026 National People’s Congress (NPC) with a sense of witnessing a subtle, yet tectonic, rearrangement of the furniture in the house of global power.
There is a particular kind of quiet that falls over a room when a long-held collective assumption evaporates. For months, the financial zeitgeist was anchored to a single date: June 2026. It was supposed to be our threshold, the moment the Federal Reserve finally pivoted and ushered us back into the “Cheap Money Era.” But as the recent data suggests, Mother Inflation has a cruel sense of timing.
There is a peculiar rhythm to the capital markets, a cadence that often shifts from a triumphal march to a sudden, contemplative silence. For the past several weeks, the South Korean market enjoyed what many called a “victory lap”—a robust 12% rally that seemed to defy the gravity of global tensions. Yet, today, the carpet was unceremoniously pulled out. The KOSPI closed at 5,609.95, a 1.84% decline that feels more like a “mental break” than a mere statistic.
수많은 쿠션 파운데이션 유목민들이 결국 ‘티르티르’로 정착하는 데는 그만한 이유가 있습니다. 제가 이 핑크색 ‘마스크 핏 올커버 쿠션’을 강력 추천하는 이유는 이름 그대로 ‘압도적인 커버력’과 ‘미친 밀착력’ 때문입니다.